Literature DB >> 2151710

The elastase-mediated pathway of fibrinolysis.

R Machovich1, W G Owen.   

Abstract

Plasmin and elastase degrade fibrin and inhibit the blood coagulation system by degrading key proteins. Elastase can facilitate plasmin expression via an alternative pathway of plasminogen activation. Elastase modifies plasminogen to yield a zymogen that is a better substrate for activators than native plasminogen. Furthermore, elastase inactivates the inhibitor system of plasmin and plasminogen activators without affecting plasmin and plasminogen activators. While plasmin activity develops from a blood zymogen as a consequence of activators synthesized and secreted by endothelium and possibly other cells, elastase is secreted in an active form primarily by polymorphonuclear leukocytes. Plasmin and elastase may play mutual roles in thrombolysis, inflammation, and tumour invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2151710     DOI: 10.1097/00001721-199003000-00011

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  12 in total

1.  Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis.

Authors:  A Stadnicki; M Gonciarz; T J Niewiarowski; J Hartleb; M Rudnicki; N B Merrell; R A Dela Cadena; R W Colman
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

2.  Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.

Authors:  Steffen Massberg; Lenka Grahl; Marie-Luise von Bruehl; Davit Manukyan; Susanne Pfeiler; Christian Goosmann; Volker Brinkmann; Michael Lorenz; Kiril Bidzhekov; Avinash B Khandagale; Ildiko Konrad; Elisabeth Kennerknecht; Katja Reges; Stefan Holdenrieder; Siegmund Braun; Christoph Reinhardt; Michael Spannagl; Klaus T Preissner; Bernd Engelmann
Journal:  Nat Med       Date:  2010-08-01       Impact factor: 53.440

3.  Cloning, expression, and hemostatic activities of a disintegrin, r-mojastin 1, from the mohave rattlesnake (Crotalus scutulatus scutulatus).

Authors:  Elda E Sánchez; Sara E Lucena; Steven Reyes; Julio G Soto; Esteban Cantu; Juan Carlos Lopez-Johnston; Belsy Guerrero; Ana Maria Salazar; Alexis Rodríguez-Acosta; Jacob A Galán; W Andy Tao; John C Pérez
Journal:  Thromb Res       Date:  2010-07-02       Impact factor: 3.944

4.  Proteolytic resistance conferred to fibrinogen by von Willebrand factor.

Authors:  A Tanka-Salamon; K Kolev; R Machovich; E Komorowicz
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

5.  Ligneous conjunctivitis, hydrocephalus, hydrocele, and pulmonary involvement in a child with homozygous type I plasminogen deficiency.

Authors:  Ergin Çiftçi; Erdal Ince; Nejat Akar; Ülker Dogru; Katrin Tefs; Volker Schuster
Journal:  Eur J Pediatr       Date:  2003-04-26       Impact factor: 3.183

Review 6.  Role of cellular elements in thrombus formation and dissolution.

Authors:  N Wohner
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-07

7.  Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow.

Authors:  N Wohner; Z Keresztes; P Sótonyi; L Szabó; E Komorowicz; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2010-04-20       Impact factor: 5.824

8.  Factor XIIIA subunit and Crohn's disease.

Authors:  M Hudson; A J Wakefield; R A Hutton; E A Sankey; A P Dhillon; L More; R Sim; R E Pounder
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

9.  Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways.

Authors:  Nikolett Wohner; András Kovács; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2011-12-15       Impact factor: 3.944

10.  Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease.

Authors:  J A Foekens; Ch Ries; M P Look; C Gippner-Steppert; J G M Klijn; M Jochum
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.